We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Firmagon (Degarelix) Intermittent Therapy (FIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01512472
Recruitment Status : Terminated (acrrual target was not being met)
First Posted : January 19, 2012
Last Update Posted : October 14, 2016
Ferring Pharmaceuticals
Information provided by (Responsible Party):
Canadian Urology Research Consortium

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2017